Background and aims
Background
Overweight and obesity are major global health concerns affecting around 2 billion people worldwide [1] . Central obesity is particularly hazardous to health associating with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM). In MetS, lipid overflow will ultimately lead to fat accumulation not only around the viscera but also to non-adipose tissue such as liver, pancreas, skeletal muscle, and heart [2] . MetS increases the risk for morbidity and mortality from cardiovascular diseases including heart failure (HF) [3, 4] . Left ventricular (LV) diastolic dysfunction with preserved systolic function is an early precursor of obesity cardiomyopathy leading eventually to HF. LV diastolic dysfunction has been associated with MetS and it has been shown to correlate with ectopic fat accumulation such as increased amount of pericardial or epicardial fat or hepatic fat content [5, 6] .
Atrial fibrillation (AF) is the most common cardiac rhythm disorder and is associated with significant morbidity and mortality, especially that arising from stroke and HF, imposing a public health burden [7, 8] . The prevalence of AF increases with age from less than 0.16 % in people younger than 49 years to over 10 % in persons aged over 80 years [7] . AF is commonly associated with overweight and obesity while other major risk factors include male sex, hypertension, HF, coronary artery disease, diabetes, sleep apnea, and excessive alcohol use [8] .
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In obese patients without AF, left atrial (LA) enlargement has been related to hypertension and LV dysfunction [9] . However, magnetic resonance imaging (MRI) data regarding LA function in MetS is limited. Atrial remodeling is defined as a spectrum of pathophysiological changes in atrial structure and function that occur in response to stresses imposed by conditions such as hypertension, HF, T2DM, and obesity [10] . Atrial remodeling may be subdivided to structural remodeling, as measured by LA size, and mechanical remodeling, as measured by LA function. Milder, often subclinical forms of atrial dysfunction may show decreased LA ejection fraction (EF) without LA enlargement.
The aim of the study was to assess LA function in men with MetS without known heart diseases and to examine the association of different ectopic fat depots and cardiometabolic risk factors with LA dysfunction.
Methods

Study design
Study population consisted of 73 men from the same study cohort as previously described [5] . Subjects were allocated into two groups (MetS present and MetS absent), based on the following criteria: 1) waist circumference ≥94 cm, and 2) having ≥2 abnormal findings as per the harmonized definition of MetS [11] . Thirty-three participants fulfilled the criteria for MetS. In these participants, myocardial ischemia was excluded by means of adenosine stress perfusion MR. Exclusion criteria and medications are described in the supplemental material.
The study was approved by the Ethics Committee of the Department of Medicine, Hospital District of Helsinki and Uusimaa, and each subject provided written informed consent.
Demographics and biochemical measurements
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Body mass index (BMI), waist circumference, blood pressure measurements and blood sample examination and analysis were performed as previously described [12] .
CMR protocol and analysis
Cardiac MR images were acquired using 1.5T imager (Magnetom Avanto; Siemens, Erlangen, Germany) and analysis was performed by two radiologists with experience of CMR. Imaging parameters are provided in the supplement.
Three-chamber (3ch) oriented images were used for measuring LA area in a single plane and end-diastolic images to obtain minimum and maximum LA volumes, and to calculate EF.
Volume parameters are reported also as indexed to the subject's body surface area (BSA).
Comparison of LA assessment of 3ch prolate ellipsoid model and traditional Simpson's method, considered as gold standard, was performed for a group (n=10) of study subjects with sufficient data available for both methods. In these subjects, LA volume was
planimetered from a stack of SA cine images with Simpson's method using dedicated software (QMass MR v.7.6, Medis Medical Imaging Systems, Leiden, Netherlands).
Quantification of cardiac, hepatic and abdominal fat depots by MRI and 1 H-MRS
For measuring myocardial and hepatic triglyceride (TG) content, 1 H-magnetic resonance spectroscopy ( 1 H-MRS) was performed in a 1.5T MR imager (Magnetom Avanto; Siemens).
MRS protocol is presented in the supplement. Distributions of visceral and subcutaneous adipose tissue (VAT and SAT) and epicardial and pericardial fat were measured as previously described [5, 12] .
Statistical analyses
All 
Results
Clinical and biochemical characteristics, body fat distribution and CMR data
Demographic differences between groups (Table 1 ) have been reported earlier in detail [5] .
Briefly, subjects with MetS were older, had larger waist circumference, and higher BMI and blood pressure than subjects without MetS. All ectopic fat depots were larger in subjects with MetS than in controls. More unfavorable plasma lipid profile and markers of glucose metabolism were noted in participants with MetS as compared to controls.
LA CMR data is outlined in Table 1 . BSA-indexed LA areas (2D model) or volumes (3D model) did not differ between groups. In 2D and 3D models, LA EF was higher in the group without MetS than in the MetS group. LV data ( Table 1 in supplemental material) have been reported earlier [5] . Univariate linear regression analysis was performed for the 3D model of LA EF (Table 3 ).
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In age-adjusted linear regression model, regression coefficients with LA EF and waist circumference, BMI, SAT, VAT, fasting serum insulin, HOMA-IR index, and HDL were significant. Stepwise multivariable regression analysis was performed to further examine the relationship of ectopic fat depots and LA EF (Table 4) . It revealed that VAT followed by SAT were the best predictors of reduced LA EF when age, BMI, and hepatic TG content were taken into account. At the late phase of LV diastole, LA acts as a pump boosting LV filling. In HF, with sustained increases in LV and LA pressure, LA dilatation occurs and LA contractile reserve becomes exhausted. In end-stage HF, this leads to a change of LA to a passive conduit dictated by ventricular distensibility [14] . In AF, the pump function of LA is lost due to dyssynchronous contraction of myocytes.
We found that in MetS, LA function is decreased as measured by LA EF without the enlargement of LA. Notably, our study subjects were asymptomatic and excluded for known heart diseases, including coronary artery disease, AF, and (clinical) heart failure. The decrease in LA EF indicates the presence of LA mechanical remodeling, an entity with increasing interest in the recent literature [10, 15] . When comparing LA measurements to patient outcomes, LA EF was found superior and incremental to LA volume with regard to the assessment of mortality risk in general population [16] . Lower LA EF has also been associated with a poorer prognosis in patients with HF [17] and non-ischemic cardiomyopathies [18] . LA remodeling can be reversible, especially at early stages, and may be treated with medications such as angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists [19] . Echocardiographic studies have also shown improved atrial function with weight loss [20] .
Obesity and MetS are well-known risk factors of AF and decreased LA EF has been shown to increase the risk for AF independent of LA size [17, 21] . Among other causes, functional LA remodeling has been suggested as a factor preceding AF. However, the pathophysiological mechanisms of atrial remodeling and development of AF in obesity are complex and remain elusive. They include unfavorable genotype and lifestyle risk factors such as sleep apnea, hypertension, hyperlipidemia, T2DM, alcohol, and smoking, impaired diastolic function causing atrial stretch, focal adiposity, and inflammation resulting in scar tissue [8] .
Consequently, structural, functional and electrical changes occur forming the substrate for AF. Evaluating LA function with a relatively simple 3ch CMR method may hence provide valuable clinical information to find particularly those obese persons at risk for developing AF or other cardiovascular events.
In our study, obesity and visceral obesity in particular were associated with LA dysfunction. Interestingly, with the exception of blood pressure, all other components (waist circumference, insulin resistance and dyslipidemia (low HDL)) of MetS were related to LA dysfunction. Waist and VAT were better predictors of LA dysfunction than BMI thus emphasizing the role of visceral obesity in LA remodeling respectively as earlier reported in LV remodeling [5] . In a recent population-based study, LA enlargement was associated with visceral obesity, but LA function was not evaluated [22] . In our study, liver fat was also associated with lower LA EF, but correlation did not remain significant after adjusting for age.
Insulin resistance is a key component of MetS associated with several pathogenetic abnormalities that lead to HF and increase cardiovascular mortality [4] . In our non-diabetic study population, insulin resistance was associated with LA dysfunction as shown by inverse M A N U S C R I P T
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correlation of blood glucose and insulin levels, and HOMA-IR index with LA EF. Our finding is in line with an earlier MRI study reporting an association of T2DM and lowered LA EF [23] .
Mechanisms to explain the role of obesity, insulin resistance or T2DM in cardiac dysfunction are diverse. Those include abnormalities in contractile proteins, impaired relaxation or contraction, impairment of glucose transport, influx of free fatty acids leading to increase of β-oxidation, oxidative stress, and lipotoxicity; impairment of microvascular circulation, and neurohormonal and sympathetic nervous system activation [4] . Neurohormonal abnormalities include imbalance of adipokine production, and overactivity of reninangiotensin-aldosterone and endocannabinoid system. Adipokines are bioactive substances produced by adipose tissue and they largely function as modulators of inflammation [24] .
Visceral obesity in particular leads to the upregulation of proinflammatory adipokines and the downregulation of anti-inflammatory adipokines which contribute to the pathogenesis of cardiovascular diseases. Additionally, renin-angiotensin system is contributor to and target of many components of MetS [4] . At the cardiac level increased angiotensin 2 activity promotes oxidative stress, and at the vascular level angiotensin 2 overproduction from hypertrophic adipocytes in obesity contribute to hypertension.
In our study population, cardiac steatosis was not a key factor of LA dysfunction although association of myocardial TG content with reduced LA EF in 2D model was noted. To our knowledge, there are no earlier 1 H-MRS studies where myocardial TG content has been examined in atrial dysfunction or AF. In contrast to other main ectopic fat depots, intramyocytic TG is not a stable deposit of adipose tissue, but a relatively rapidly changing pool of lipids where up to three or four-fold increase has been reported following 48-72 h fasting in lean subjects [25] . In the ventricles, normal heart utilizes fatty acids and glucose as main energy sources with a ratio of 3:1 [26] . In the setting of obesity, the balance is shifted M A N U S C R I P T
more towards consumption of fatty acids due to increased β-oxidation [27] . Under aerobic conditions, fatty acid oxidation yields more adenosine triphosphate (ATP) per gram of substrate but takes 10-15% more O 2 per amount of ATP than glucose [28] . During chronic hypoxia and heart failure, ventricular metabolism shifts from fatty acid to glucose utilization.
For the atria, substrate preference has not been investigated but it may not differ from that in the ventricles [28] . Analogously, whether the measurement of the myocardial TG content from the ventricular septal wall corresponds to the TG content of the LA myocardium is unclear. Theroretically, myocardial TG content may act ambiguously in obesity-related subclinical atrial dysfunction, as it may increase due to accelerated free fatty acid uptake and β-oxidation, and decrease in response to the higher energy demand, oxidative stress, and increased glycolysis. In conclusion, the dynamical role of intramyocytic lipids will merit further studies.
Limitations
Study population was limited to men to exclude the effects of hormonal variability. As a potential source of bias, MetS subjects were older than controls. According to previous cross-sectional imaging studies in normal population, data concerning LA remodeling in aging is inconsistent. Earlier studies showed no significant influence of age on LA volume and function [29] [30] [31] but in recent study by Maceira et al. [32] , a mild age influence on LA function was found. In our control population of 40 men, age did not correlate with LA size or function, but we still performed an age-adjustment for the linear regression analyses.
Another source of bias is that the measurement of LA volume did not cover the whole volume of LA but was based on a single image plane of 3ch images with the third dimension taken into account by measuring the LA diameter in perpendicular SA plane. Absolute LA M A N U S C R I P T A C C E P T E D Acknowledgements M A N U S C R I P T
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Highlights
• Metabolic syndrome associates with subclinical left atrial dysfunction.
• Multiple components of metabolic syndrome are related to left atrial dysfunction.
• Visceral fat was the best ectopic fat deposit to predict left atrial dysfunction.
• Role of cardiac steatosis in left atrial dysfunction was not essential.
